Exchange: NASDAQ·Updated 07:12 PM EDT
ALLR logo

ALLR Allarity Therapeutics Inc

$0.88
$0.0028
(0.32%)
Today
Closed $0.8758
$0.0042
(0.48%)
After Hours
Mkt Cap$13.89M
Vol108,540.00

About ALLR

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments. The company is focused on development of stenoparib, a novel PARP and tankyrase inhibitor for advanced ovarian cancer patients, using its DRP technology to develop a companion diagnostic that can be used to select those patients expected to derive the greatest clinical benefit from stenoparib. Allarity Therapeutics was founded by Steen Knudsen and Thomas H. Jensen in 2004 and is headquartered in Tarpon Springs, FL.
63

Bullish Sentiment

How do you feel about ALLR?

Wody
$ALLR cmon Jensen you fucking cunt, release the data, tell us phase 3 has started so I can move on!
1
4
johnny6nine
$ALLR this usually dumps hard before news…. done it in the past multiple times. hopefully a PR is on the near horizon
7
BetterDayzz
$ALLR It’ll recover, it always does. Not sure what kind of fackery happened today. In hindsight would’ve been nice to buy back in on a day like this but my fomo led me to buy back last week. Still ultra confident!
6
ka1954
$ALLR people giving up on this. most micro cap stocks are in the toilet last 2-3 months. rate hike cycle continuing
4
RAKIN13
$ALLR tired tbh, I don’t want to hear TJ joining other boards anymore. Focus on your prime asset, give us the news that all investors have been patiently waiting for
4
biotrade123
$ALLR if the ceo is so confident of steno, the least he can do is perhaps buy some substantial stock with his own money in the open market to reassure retail.
4
focafoca99
$ALLR outlined recent advances in its DRP technology, patent portfolio and lab capabilities to support stenoparib development.
4
johnny6nine
$ALLR Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development - Recently awarded patents have solidified Allarity’s strategy to leverage DRP to ensure the commercial exclusivity of stenoparib
4
Dizzier47
$ALLR it literally doesnt matter if it goes to 0.01$ by the end of the year. the data is all that matters here ppl can sell off in times of uncertainty all they want
4
RAKIN13
$ALLR just want to break even. This ceo is a fucking liar. Inflection year my ass. He’s fucked up everything. His lack of focus has caused this all because of a stupid SPAC. This is such a shit show I’m done
3
RAKIN13
$ALLR fuck Jensen, this guy lost focus and the stock is messing up. When is this news out? Absolute joke
3
sixmilliondollarman
$ALLR individual below, you may want to trade another sector. Biotech requires some specialized knowledge like knowing that continuous MoA characterization in P2 is standard industry practice to de-risk P 3 protocol design. 🤷‍♂️
3
ka1954
$ALLR people scared. i dont blame them. all micro cap stocks are being decimated for last 2-3 months. recently this decimation has been more than usual
2
Jtrain5151
$ALLR I’ve never hated a stock as much as this one. Terrible leadership in this company.
2
Steviep951
$ALLR Woo, Senior Analyst for Ascendiant Capital, sole $11 broker rating Allarity has an ATM agreement under which Ascendiant acts as the sales agent for ALLR shares and receives a 3% commission on shares sold through the facility. Allarity's SEC filing explicitly discloses that relationship... JFC
2
Tobster9756
$ALLR price action is of course frustrating but there has been no material change here. Data is still the most important thing…
2
ka1954
$ALLR so many turds have gone up 200%+ so easily in last few weeks/months. this also could have gone up so easily. Traders just didn't pick ALLR to go up, what luck !!!
2
gscdefense
$ALLR Is the buyback still in effect? I walked away from this 2 years ago with some nasty losses. Jensen sucks ass but the stock has real potential. Does anyone track daily O/S to see generally where the buyback program is at?
1
Popsiclestick
$ALLR maybe jensen is shorting both stocks in which he is apart of. ALLr and VBIO suck today…
1
CantAffordMe
$ALLR The PR today acknowledges that stenoparib still needs more research and development. jensen is doing his best to dance around the fact that the company is dead in the water.
1

Advertisement|Remove ads.